Difference between revisions of "User:Bailey.Glen"

From Compendium of Cancer Genome Aberrations
Jump to navigation Jump to search
VisualWikitext
Line 12: Line 12:
 
|-
 
|-
  
−
|[[BRST5:Usual_ductal_hyperplasia|Usual ductal hyperplasia]]
+
|[[CNS5:Astrocytoma,_IDH-mutant|Astrocytoma, IDH-mutant]]
 
|Disease
 
|Disease
 
|
 
|
Line 23: Line 23:
 
|
 
|
 
|-
 
|-
−
|[[BRST5:Columnar_cell_lesions,_including_flat_epithelial_atypia_|Columnar cell lesions, including flat epithelial atypia ]]
+
|[[CNS5:Oligodendroglioma,_IDH-mutant_and_1p/19q-codeleted|Oligodendroglioma, IDH-mutant and 1p/19q-codeleted]]
 
|Disease
 
|Disease
 
|
 
|
Line 34: Line 34:
 
|
 
|
 
|-
 
|-
−
|[[BRST5:Atypical_ductal_hyperplasia|Atypical ductal hyperplasia]]
+
|[[CNS5:Glioblastoma,_IDH-wildtype|Glioblastoma, IDH-wildtype]]
 
|Disease
 
|Disease
 
|
 
|
Line 45: Line 45:
 
|
 
|
 
|-
 
|-
−
|[[BRST5:Sclerosing_adenosis|Sclerosing adenosis]]
+
|[[CNS5:Diffuse_astrocytoma,_MYB-_or_MYBL1-altered|Diffuse astrocytoma, MYB- or MYBL1-altered]]
 
|Disease
 
|Disease
 
|
 
|
Line 56: Line 56:
 
|
 
|
 
|-
 
|-
−
|[[BRST5:Apocrine_adenosis_and_adenoma|Apocrine adenosis and adenoma]]
+
|[[CNS5:Angiocentric_glioma|Angiocentric glioma]]
 
|Disease
 
|Disease
 
|
 
|
Line 67: Line 67:
 
|
 
|
 
|-
 
|-
−
|[[BRST5:Microglandular_adenosis_|Microglandular adenosis ]]
+
|[[CNS5:Polymorphous_low-grade_neuroepithelial_tumour_of_the_young|Polymorphous low-grade neuroepithelial tumour of the young]]
 
|Disease
 
|Disease
 
|
 
|
Line 78: Line 78:
 
|
 
|
 
|-
 
|-
−
|[[BRST5:Radial_scar_/_complex_sclerosing_lesion_|Radial scar / complex sclerosing lesion ]]
+
|[[CNS5:Diffuse_low-grade_glioma,_MAPK_pathway-altered_|Diffuse low-grade glioma, MAPK pathway-altered ]]
 
|Disease
 
|Disease
 
|
 
|
Line 89: Line 89:
 
|
 
|
 
|-
 
|-
−
|[[BRST5:Tubular_adenoma_|Tubular adenoma ]]
+
|[[CNS5:Diffuse_midline_glioma,_H3_K27-altered|Diffuse midline glioma, H3 K27-altered]]
 
|Disease
 
|Disease
 
|
 
|
Line 100: Line 100:
 
|
 
|
 
|-
 
|-
−
|[[BRST5:Lactating_adenoma_|Lactating adenoma ]]
+
|[[CNS5:Diffuse_hemispheric_glioma,_H3_G34-mutant|Diffuse hemispheric glioma, H3 G34-mutant]]
 
|Disease
 
|Disease
 
|
 
|
Line 111: Line 111:
 
|
 
|
 
|-
 
|-
−
|[[BRST5:Ductal_adenoma|Ductal adenoma]]
+
|[[CNS5:Diffuse_paediatric-type_high-grade_glioma,_H3-wildtype_and_IDH-wildtype|Diffuse paediatric-type high-grade glioma, H3-wildtype and IDH-wildtype]]
 
|Disease
 
|Disease
 
|
 
|
Line 122: Line 122:
 
|
 
|
 
|-
 
|-
−
|[[BRST5:Pleomorphic_adenoma|Pleomorphic adenoma]]
+
|[[CNS5:Infant-type_hemispheric_glioma|Infant-type hemispheric glioma]]
 
|Disease
 
|Disease
 
|
 
|
Line 133: Line 133:
 
|
 
|
 
|-
 
|-
−
|[[BRST5:Adenomyoepithelioma|Adenomyoepithelioma]]
+
|[[CNS5:Pilocytic_astrocytoma_|Pilocytic astrocytoma ]]
 
|Disease
 
|Disease
 
|
 
|
Line 144: Line 144:
 
|
 
|
 
|-
 
|-
−
|[[BRST5:Malignant_adenomyoepithelioma|Malignant adenomyoepithelioma]]
+
|[[CNS5:High-grade_astrocytoma_with_piloid_features|High-grade astrocytoma with piloid features]]
 
|Disease
 
|Disease
 
|
 
|
Line 155: Line 155:
 
|
 
|
 
|-
 
|-
−
|[[BRST5:Intraductal_papilloma|Intraductal papilloma]]
+
|[[CNS5:Pleomorphic_xanthoastrocytoma|Pleomorphic xanthoastrocytoma]]
 
|Disease
 
|Disease
 
|
 
|
Line 166: Line 166:
 
|
 
|
 
|-
 
|-
−
|[[BRST5:Papillary_ductal_carcinoma_in_situ|Papillary ductal carcinoma in situ]]
+
|[[CNS5:Subependymal_giant_cell_astrocytoma|Subependymal giant cell astrocytoma]]
 
|Disease
 
|Disease
 
|
 
|
Line 177: Line 177:
 
|
 
|
 
|-
 
|-
−
|[[BRST5:Encapsulated_papillary_carcinoma|Encapsulated papillary carcinoma]]
+
|[[CNS5:Chordoid_glioma|Chordoid glioma]]
 
|Disease
 
|Disease
 
|
 
|
Line 188: Line 188:
 
|
 
|
 
|-
 
|-
−
|[[BRST5:Solid_papillary_carcinoma_(in_situ_and_invasive)|Solid papillary carcinoma (in situ and invasive)]]
+
|[[CNS5:Astroblastoma,_MN1-altered|Astroblastoma, MN1-altered]]
 
|Disease
 
|Disease
 
|
 
|
Line 199: Line 199:
 
|
 
|
 
|-
 
|-
−
|[[BRST5:Invasive_papillary_carcinoma|Invasive papillary carcinoma]]
+
|[[CNS5:Ganglioglioma|Ganglioglioma]]
 
|Disease
 
|Disease
 
|
 
|
Line 210: Line 210:
 
|
 
|
 
|-
 
|-
−
|[[BRST5:Atypical_lobular_hyperplasia_|Atypical lobular hyperplasia ]]
+
|[[CNS5:Gangliocytoma|Gangliocytoma]]
 
|Disease
 
|Disease
 
|
 
|
Line 221: Line 221:
 
|
 
|
 
|-
 
|-
−
|[[BRST5:Lobular_carcinoma_in_situ|Lobular carcinoma in situ]]
+
|[[CNS5:Desmoplastic_infantile_ganglioglioma_/_desmoplastic_infantile_astrocytoma|Desmoplastic infantile ganglioglioma / desmoplastic infantile astrocytoma]]
 
|Disease
 
|Disease
 
|
 
|
Line 232: Line 232:
 
|
 
|
 
|-
 
|-
−
|[[BRST5:Ductal_carcinoma_in_situ_|Ductal carcinoma in situ ]]
+
|[[CNS5:Dysembryoplastic_neuroepithelial_tumour|Dysembryoplastic neuroepithelial tumour]]
 
|Disease
 
|Disease
 
|
 
|
Line 243: Line 243:
 
|
 
|
 
|-
 
|-
−
|[[BRST5:Invasive_breast_carcinoma:_General_overview|Invasive breast carcinoma: General overview]]
+
|[[CNS5:Diffuse_glioneuronal_tumour_with_oligodendroglioma-like_features_and_nuclear_clusters|Diffuse glioneuronal tumour with oligodendroglioma-like features and nuclear clusters]]
 
|Disease
 
|Disease
 
|
 
|
Line 254: Line 254:
 
|
 
|
 
|-
 
|-
−
|[[BRST5:Invasive_breast_carcinoma_of_no_special_type|Invasive breast carcinoma of no special type]]
+
|[[CNS5:Papillary_glioneuronal_tumour|Papillary glioneuronal tumour]]
 
|Disease
 
|Disease
 
|
 
|
Line 265: Line 265:
 
|
 
|
 
|-
 
|-
−
|[[BRST5:Microinvasive_carcinoma|Microinvasive carcinoma]]
+
|[[CNS5:Rosette-forming_glioneuronal_tumour|Rosette-forming glioneuronal tumour]]
 
|Disease
 
|Disease
 
|
 
|
Line 276: Line 276:
 
|
 
|
 
|-
 
|-
−
|[[BRST5:Invasive_lobular_carcinoma_|Invasive lobular carcinoma ]]
+
|[[CNS5:Myxoid_glioneuronal_tumour|Myxoid glioneuronal tumour]]
 
|Disease
 
|Disease
 
|
 
|
Line 287: Line 287:
 
|
 
|
 
|-
 
|-
−
|[[BRST5:Tubular_carcinoma|Tubular carcinoma]]
+
|[[CNS5:Diffuse_leptomeningeal_glioneuronal_tumour|Diffuse leptomeningeal glioneuronal tumour]]
 
|Disease
 
|Disease
 
|
 
|
Line 298: Line 298:
 
|
 
|
 
|-
 
|-
−
|[[BRST5:Cribriform_carcinoma|Cribriform carcinoma]]
+
|[[CNS5:Multinodular_and_vacuolating_neuronal_tumour|Multinodular and vacuolating neuronal tumour]]
 
|Disease
 
|Disease
 
|
 
|
Line 309: Line 309:
 
|
 
|
 
|-
 
|-
−
|[[BRST5:Mucinous_carcinoma|Mucinous carcinoma]]
+
|[[CNS5:Dysplastic_cerebellar_gangliocytoma_(Lhermitte-Duclos_disease)|Dysplastic cerebellar gangliocytoma (Lhermitte-Duclos disease)]]
 
|Disease
 
|Disease
 
|
 
|
Line 320: Line 320:
 
|
 
|
 
|-
 
|-
−
|[[BRST5:Mucinous_cystadenocarcinoma|Mucinous cystadenocarcinoma]]
+
|[[CNS5:Central_neurocytoma|Central neurocytoma]]
 
|Disease
 
|Disease
 
|
 
|
Line 331: Line 331:
 
|
 
|
 
|-
 
|-
−
|[[BRST5:Invasive_micropapillary_carcinoma|Invasive micropapillary carcinoma]]
+
|[[CNS5:Extraventricular_neurocytoma|Extraventricular neurocytoma]]
 
|Disease
 
|Disease
 
|
 
|
Line 342: Line 342:
 
|
 
|
 
|-
 
|-
−
|[[BRST5:Carcinoma_with_apocrine_differentiation|Carcinoma with apocrine differentiation]]
+
|[[CNS5:Cerebellar_liponeurocytoma|Cerebellar liponeurocytoma]]
 
|Disease
 
|Disease
 
|
 
|
Line 353: Line 353:
 
|
 
|
 
|-
 
|-
−
|[[BRST5:Metaplastic_carcinoma|Metaplastic carcinoma]]
+
|[[CNS5:Supratentorial_ependymoma|Supratentorial ependymoma]]
 
|Disease
 
|Disease
 
|
 
|
Line 364: Line 364:
 
|
 
|
 
|-
 
|-
−
|[[BRST5:Acinic_cell_carcinoma|Acinic cell carcinoma]]
+
|[[CNS5:Supratentorial_ependymoma,_ZFTA_fusion-positive_|Supratentorial ependymoma, ZFTA fusion-positive ]]
 
|Disease
 
|Disease
 
|
 
|
Line 375: Line 375:
 
|
 
|
 
|-
 
|-
−
|[[BRST5:Adenoid_cystic_carcinoma|Adenoid cystic carcinoma]]
+
|[[CNS5:Supratentorial_ependymoma,_YAP1_fusion-positive|Supratentorial ependymoma, YAP1 fusion-positive]]
 
|Disease
 
|Disease
 
|
 
|
Line 386: Line 386:
 
|
 
|
 
|-
 
|-
−
|[[BRST5:Secretory_carcinoma_|Secretory carcinoma ]]
+
|[[CNS5:Posterior_fossa_ependymoma|Posterior fossa ependymoma]]
 
|Disease
 
|Disease
 
|
 
|
Line 397: Line 397:
 
|
 
|
 
|-
 
|-
−
|[[BRST5:Mucoepidermoid_carcinoma|Mucoepidermoid carcinoma]]
+
|[[CNS5:Posterior_fossa_group_A_(PFA)_ependymoma|Posterior fossa group A (PFA) ependymoma]]
 
|Disease
 
|Disease
 
|
 
|
Line 408: Line 408:
 
|
 
|
 
|-
 
|-
−
|[[BRST5:Polymorphous_adenocarcinoma|Polymorphous adenocarcinoma]]
+
|[[CNS5:Posterior_fossa_group_B_(PFB)_ependymoma|Posterior fossa group B (PFB) ependymoma]]
 
|Disease
 
|Disease
 
|
 
|
Line 419: Line 419:
 
|
 
|
 
|-
 
|-
−
|[[BRST5:Tall_cell_carcinoma_with_reversed_polarity|Tall cell carcinoma with reversed polarity]]
+
|[[CNS5:Spinal_ependymoma|Spinal ependymoma]]
 
|Disease
 
|Disease
 
|
 
|
Line 430: Line 430:
 
|
 
|
 
|-
 
|-
−
|[[BRST5:Neuroendocrine_tumour|Neuroendocrine tumour]]
+
|[[CNS5:Spinal_ependymoma,_MYCN-amplified|Spinal ependymoma, MYCN-amplified]]
 
|Disease
 
|Disease
 
|
 
|
Line 441: Line 441:
 
|
 
|
 
|-
 
|-
−
|[[BRST5:Neuroendocrine_carcinoma|Neuroendocrine carcinoma]]
+
|[[CNS5:Myxopapillary_ependymoma|Myxopapillary ependymoma]]
 
|Disease
 
|Disease
 
|
 
|
Line 452: Line 452:
 
|
 
|
 
|-
 
|-
−
|[[BRST5:Hamartoma_|Hamartoma ]]
+
|[[CNS5:Subependymoma|Subependymoma]]
 
|Disease
 
|Disease
 
|
 
|
Line 463: Line 463:
 
|
 
|
 
|-
 
|-
−
|[[BRST5:Fibroadenoma_|Fibroadenoma ]]
+
|[[CNS5:Choroid_plexus_papilloma|Choroid plexus papilloma]]
 
|Disease
 
|Disease
 
|
 
|
Line 474: Line 474:
 
|
 
|
 
|-
 
|-
−
|[[BRST5:Phyllodes_tumour_|Phyllodes tumour ]]
+
|[[CNS5:Atypical_choroid_plexus_papilloma|Atypical choroid plexus papilloma]]
 
|Disease
 
|Disease
 
|
 
|
Line 485: Line 485:
 
|
 
|
 
|-
 
|-
−
|[[BRST5:Syringomatous_tumour_|Syringomatous tumour ]]
+
|[[CNS5:Choroid_plexus_carcinoma|Choroid plexus carcinoma]]
 
|Disease
 
|Disease
 
|
 
|
Line 496: Line 496:
 
|
 
|
 
|-
 
|-
−
|[[BRST5:Nipple_adenoma_|Nipple adenoma ]]
+
|[[CNS5:Medulloblastoma,_WNT-activated|Medulloblastoma, WNT-activated]]
 
|Disease
 
|Disease
 
|
 
|
Line 507: Line 507:
 
|
 
|
 
|-
 
|-
−
|[[BRST5:Paget_disease_of_the_breast|Paget disease of the breast]]
+
|[[CNS5:Medulloblastoma,_SHH-activated_and_TP53-wildtype|Medulloblastoma, SHH-activated and TP53-wildtype]]
 
|Disease
 
|Disease
 
|
 
|
Line 518: Line 518:
 
|
 
|
 
|-
 
|-
−
|[[BRST5:Haemangioma|Haemangioma]]
+
|[[CNS5:Medulloblastoma,_SHH-activated_and_TP53-mutant|Medulloblastoma, SHH-activated and TP53-mutant]]
 
|Disease
 
|Disease
 
|
 
|
Line 529: Line 529:
 
|
 
|
 
|-
 
|-
−
|[[BRST5:Angiomatosis|Angiomatosis]]
+
|[[CNS5:Medulloblastoma,_non-WNT/non-SHH|Medulloblastoma, non-WNT/non-SHH]]
 
|Disease
 
|Disease
 
|
 
|
Line 540: Line 540:
 
|
 
|
 
|-
 
|-
−
|[[BRST5:Atypical_vascular_lesions_|Atypical vascular lesions ]]
+
|[[CNS5:Medulloblastoma,_histologically_defined|Medulloblastoma, histologically defined]]
 
|Disease
 
|Disease
 
|
 
|
Line 551: Line 551:
 
|
 
|
 
|-
 
|-
−
|[[BRST5:Postradiation_angiosarcoma_of_the_breast|Postradiation angiosarcoma of the breast]]
+
|[[CNS5:Atypical_teratoid/rhabdoid_tumour|Atypical teratoid/rhabdoid tumour]]
 
|Disease
 
|Disease
 
|
 
|
Line 562: Line 562:
 
|
 
|
 
|-
 
|-
−
|[[BRST5:Primary_angiosarcoma_of_the_breast|Primary angiosarcoma of the breast]]
+
|[[CNS5:Cribriform_neuroepithelial_tumour|Cribriform neuroepithelial tumour]]
 
|Disease
 
|Disease
 
|
 
|
Line 573: Line 573:
 
|
 
|
 
|-
 
|-
−
|[[BRST5:Nodular_fasciitis|Nodular fasciitis]]
+
|[[CNS5:Embryonal_tumour_with_multilayered_rosettes|Embryonal tumour with multilayered rosettes]]
 
|Disease
 
|Disease
 
|
 
|
Line 584: Line 584:
 
|
 
|
 
|-
 
|-
−
|[[BRST5:Myofibroblastoma|Myofibroblastoma]]
+
|[[CNS5:CNS_neuroblastoma,_FOXR2-activated|CNS neuroblastoma, FOXR2-activated]]
 
|Disease
 
|Disease
 
|
 
|
Line 595: Line 595:
 
|
 
|
 
|-
 
|-
−
|[[BRST5:Desmoid_fibromatosis_|Desmoid fibromatosis ]]
+
|[[CNS5:CNS_tumour_with_BCOR_internal_tandem_duplication|CNS tumour with BCOR internal tandem duplication]]
 
|Disease
 
|Disease
 
|
 
|
Line 606: Line 606:
 
|
 
|
 
|-
 
|-
−
|[[BRST5:Inflammatory_myofibroblastic_tumour_|Inflammatory myofibroblastic tumour ]]
+
|[[CNS5:CNS_embryonal_tumour_NEC/NOS|CNS embryonal tumour NEC/NOS]]
 
|Disease
 
|Disease
 
|
 
|
Line 617: Line 617:
 
|
 
|
 
|-
 
|-
−
|[[BRST5:Schwannoma_|Schwannoma ]]
+
|[[CNS5:Pineocytoma|Pineocytoma]]
 
|Disease
 
|Disease
 
|
 
|
Line 628: Line 628:
 
|
 
|
 
|-
 
|-
−
|[[BRST5:Neurofibroma_|Neurofibroma ]]
+
|[[CNS5:Pineal_parenchymal_tumour_of_intermediate_differentiation|Pineal parenchymal tumour of intermediate differentiation]]
 
|Disease
 
|Disease
 
|
 
|
Line 639: Line 639:
 
|
 
|
 
|-
 
|-
−
|[[BRST5:Granular_cell_tumour|Granular cell tumour]]
+
|[[CNS5:Pineoblastoma|Pineoblastoma]]
 
|Disease
 
|Disease
 
|
 
|
Line 650: Line 650:
 
|
 
|
 
|-
 
|-
−
|[[BRST5:Leiomyoma|Leiomyoma]]
+
|[[CNS5:Papillary_tumour_of_the_pineal_region|Papillary tumour of the pineal region]]
 
|Disease
 
|Disease
 
|
 
|
Line 661: Line 661:
 
|
 
|
 
|-
 
|-
−
|[[BRST5:Leiomyosarcoma_|Leiomyosarcoma ]]
+
|[[CNS5:Desmoplastic_myxoid_tumour_of_the_pineal_region,_SMARCB1-mutant|Desmoplastic myxoid tumour of the pineal region, SMARCB1-mutant]]
 
|Disease
 
|Disease
 
|
 
|
Line 672: Line 672:
 
|
 
|
 
|-
 
|-
−
|[[BRST5:Lipoma_|Lipoma ]]
+
|[[CNS5:Schwannoma|Schwannoma]]
 
|Disease
 
|Disease
 
|
 
|
Line 683: Line 683:
 
|
 
|
 
|-
 
|-
−
|[[BRST5:Angiolipoma_|Angiolipoma ]]
+
|[[CNS5:Neurofibroma|Neurofibroma]]
 
|Disease
 
|Disease
 
|
 
|
Line 694: Line 694:
 
|
 
|
 
|-
 
|-
−
|[[BRST5:Liposarcoma_|Liposarcoma ]]
+
|[[CNS5:Perineurioma|Perineurioma]]
 
|Disease
 
|Disease
 
|
 
|
Line 705: Line 705:
 
|
 
|
 
|-
 
|-
−
|[[BRST5:Pseudoangiomatous_stromal_hyperplasia|Pseudoangiomatous stromal hyperplasia]]
+
|[[CNS5:Hybrid_nerve_sheath_tumours|Hybrid nerve sheath tumours]]
 
|Disease
 
|Disease
 
|
 
|
Line 716: Line 716:
 
|
 
|
 
|-
 
|-
−
|[[BRST5:Extranodal_marginal_zone_lymphoma_of_mucosa-associated_lymphoid_tissue_(MALT_lymphoma)|Extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue (MALT lymphoma)]]
+
|[[CNS5:Malignant_melanotic_nerve_sheath_tumour|Malignant melanotic nerve sheath tumour]]
 
|Disease
 
|Disease
 
|
 
|
Line 727: Line 727:
 
|
 
|
 
|-
 
|-
−
|[[BRST5:Follicular_lymphoma_|Follicular lymphoma ]]
+
|[[CNS5:Malignant_peripheral_nerve_sheath_tumour|Malignant peripheral nerve sheath tumour]]
 
|Disease
 
|Disease
 
|
 
|
Line 738: Line 738:
 
|
 
|
 
|-
 
|-
−
|[[BRST5:Diffuse_large_B-cell_lymphoma_|Diffuse large B-cell lymphoma ]]
+
|[[CNS5:Cauda_equina_neuroendocrine_tumour_(previously_paraganglioma)|Cauda equina neuroendocrine tumour (previously paraganglioma)]]
 
|Disease
 
|Disease
 
|
 
|
Line 749: Line 749:
 
|
 
|
 
|-
 
|-
−
|[[BRST5:Burkitt_lymphoma|Burkitt lymphoma]]
+
|[[CNS5:Meningioma|Meningioma]]
 
|Disease
 
|Disease
 
|
 
|
Line 760: Line 760:
 
|
 
|
 
|-
 
|-
−
|[[BRST5:Breast_implant-associated_anaplastic_large_cell_lymphoma_|Breast implant-associated anaplastic large cell lymphoma ]]
+
|[[CNS5:Solitary_fibrous_tumour|Solitary fibrous tumour]]
 
|Disease
 
|Disease
 
|
 
|
Line 771: Line 771:
 
|
 
|
 
|-
 
|-
−
|[[BRST5:Gynaecomastia|Gynaecomastia]]
+
|[[CNS5:Haemangiomas_and_vascular_malformations|Haemangiomas and vascular malformations]]
 
|Disease
 
|Disease
 
|
 
|
Line 782: Line 782:
 
|
 
|
 
|-
 
|-
−
|[[BRST5:Carcinoma_in_situ|Carcinoma in situ]]
+
|[[CNS5:Haemangioblastoma|Haemangioblastoma]]
 
|Disease
 
|Disease
 
|
 
|
Line 793: Line 793:
 
|
 
|
 
|-
 
|-
−
|[[BRST5:Invasive_carcinoma|Invasive carcinoma]]
+
|[[CNS5:Rhabdomyosarcoma|Rhabdomyosarcoma]]
 
|Disease
 
|Disease
 
|
 
|
Line 804: Line 804:
 
|
 
|
 
|-
 
|-
−
|[[BRST5:Metastases_to_the_breast|Metastases to the breast]]
+
|[[CNS5:Intracranial_mesenchymal_tumour,_FET::CREB_fusion-positive|Intracranial mesenchymal tumour, FET::CREB fusion-positive]]
 
|Disease
 
|Disease
 
|
 
|
Line 815: Line 815:
 
|
 
|
 
|-
 
|-
−
|[[BRST5:BRCA1/2-associated_hereditary_breast_and_ovarian_cancer_syndrome|BRCA1/2-associated hereditary breast and ovarian cancer syndrome]]
+
|[[CNS5:CIC-rearranged_sarcoma|CIC-rearranged sarcoma]]
 
|Disease
 
|Disease
 
|
 
|
Line 826: Line 826:
 
|
 
|
 
|-
 
|-
−
|[[BRST5:Cowden_syndrome|Cowden syndrome]]
+
|[[CNS5:Primary_intracranial_sarcoma,_DICER1-mutant|Primary intracranial sarcoma, DICER1-mutant]]
 
|Disease
 
|Disease
 
|
 
|
Line 837: Line 837:
 
|
 
|
 
|-
 
|-
−
|[[BRST5:Ataxia-telangiectasia|Ataxia-telangiectasia]]
+
|[[CNS5:Ewing_sarcoma|Ewing sarcoma]]
 
|Disease
 
|Disease
 
|
 
|
Line 848: Line 848:
 
|
 
|
 
|-
 
|-
−
|[[BRST5:Li-Fraumeni_syndrome,_TP53-associated|Li-Fraumeni syndrome, TP53-associated]]
+
|[[CNS5:Mesenchymal_chondrosarcoma|Mesenchymal chondrosarcoma]]
 
|Disease
 
|Disease
 
|
 
|
Line 859: Line 859:
 
|
 
|
 
|-
 
|-
−
|[[BRST5:Li-Fraumeni_syndrome,_CHEK2-associated|Li-Fraumeni syndrome, CHEK2-associated]]
+
|[[CNS5:Chondrosarcoma|Chondrosarcoma]]
 
|Disease
 
|Disease
 
|
 
|
Line 870: Line 870:
 
|
 
|
 
|-
 
|-
−
|[[BRST5:CDH1-associated_breast_cancer|CDH1-associated breast cancer]]
+
|[[CNS5:Chordoma|Chordoma]]
 
|Disease
 
|Disease
 
|
 
|
Line 881: Line 881:
 
|
 
|
 
|-
 
|-
−
|[[BRST5:PALB2-associated_cancers|PALB2-associated cancers]]
+
|[[CNS5:Diffuse_meningeal_melanocytic_neoplasms:_Melanocytosis_and_melanomatosis|Diffuse meningeal melanocytic neoplasms: Melanocytosis and melanomatosis]]
 
|Disease
 
|Disease
 
|
 
|
Line 892: Line 892:
 
|
 
|
 
|-
 
|-
−
|[[BRST5:Peutz-Jeghers_syndrome|Peutz-Jeghers syndrome]]
+
|[[CNS5:Circumscribed_meningeal_melanocytic_neoplasms:_Melanocytoma_and_melanoma|Circumscribed meningeal melanocytic neoplasms: Melanocytoma and melanoma]]
 
|Disease
 
|Disease
 
|
 
|
Line 903: Line 903:
 
|
 
|
 
|-
 
|-
−
|[[BRST5:Neurofibromatosis_type_1|Neurofibromatosis type 1]]
+
|[[CNS5:Primary_diffuse_large_B-cell_lymphoma_of_the_CNS|Primary diffuse large B-cell lymphoma of the CNS]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[CNS5:Immunodeficiency-associated_CNS_lymphomas|Immunodeficiency-associated CNS lymphomas]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[CNS5:Lymphomatoid_granulomatosis|Lymphomatoid granulomatosis]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[CNS5:Intravascular_large_B-cell_lymphoma|Intravascular large B-cell lymphoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[CNS5:MALT_lymphoma_of_the_dura|MALT lymphoma of the dura]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[CNS5:Other_low-grade_B-cell_lymphomas_of_the_CNS|Other low-grade B-cell lymphomas of the CNS]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[CNS5:Anaplastic_large_cell_lymphoma_(ALK+/ALK−)|Anaplastic large cell lymphoma (ALK+/ALK−)]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[CNS5:T-cell_and_NK/T-cell_lymphomas|T-cell and NK/T-cell lymphomas]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[CNS5:Erdheim-Chester_disease|Erdheim-Chester disease]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[CNS5:Rosai-Dorfman_disease|Rosai-Dorfman disease]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[CNS5:Juvenile_xanthogranuloma|Juvenile xanthogranuloma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[CNS5:Langerhans_cell_histiocytosis|Langerhans cell histiocytosis]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[CNS5:Histiocytic_sarcoma|Histiocytic sarcoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[CNS5:Germ_cell_tumours_of_the_CNS|Germ cell tumours of the CNS]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[CNS5:Adamantinomatous_craniopharyngioma|Adamantinomatous craniopharyngioma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[CNS5:Papillary_craniopharyngioma|Papillary craniopharyngioma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[CNS5:Pituicytoma,_granular_cell_tumour_of_the_sellar_region,_and_spindle_cell_oncocytoma|Pituicytoma, granular cell tumour of the sellar region, and spindle cell oncocytoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[CNS5:Pituitary_adenoma_/_pituitary_neuroendocrine_tumour|Pituitary adenoma / pituitary neuroendocrine tumour]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[CNS5:Pituitary_blastoma|Pituitary blastoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[CNS5:Metastases_to_the_brain_and_spinal_cord_parenchyma|Metastases to the brain and spinal cord parenchyma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[CNS5:Metastases_to_the_meninges|Metastases to the meninges]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[CNS5:Neurofibromatosis_type_1|Neurofibromatosis type 1]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[CNS5:Neurofibromatosis_type_2|Neurofibromatosis type 2]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[CNS5:Schwannomatosis|Schwannomatosis]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[CNS5:Von_Hippel-Lindau_syndrome|Von Hippel-Lindau syndrome]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[CNS5:Tuberous_sclerosis|Tuberous sclerosis]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[CNS5:Li-Fraumeni_syndrome|Li-Fraumeni syndrome]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[CNS5:Cowden_syndrome|Cowden syndrome]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[CNS5:Constitutional_mismatch_repair_deficiency_syndrome|Constitutional mismatch repair deficiency syndrome]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[CNS5:Familial_adenomatous_polyposis_1|Familial adenomatous polyposis 1]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[CNS5:Naevoid_basal_cell_carcinoma_syndrome|Naevoid basal cell carcinoma syndrome]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[CNS5:Rhabdoid_tumour_predisposition_syndrome|Rhabdoid tumour predisposition syndrome]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[CNS5:Carney_complex|Carney complex]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[CNS5:DICER1_syndrome|DICER1 syndrome]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[CNS5:Familial_paraganglioma_syndromes|Familial paraganglioma syndromes]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[CNS5:Melanoma-astrocytoma_syndrome|Melanoma-astrocytoma syndrome]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[CNS5:Familial_retinoblastoma|Familial retinoblastoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[CNS5:BAP1_tumour_predisposition_syndrome|BAP1 tumour predisposition syndrome]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[CNS5:Fanconi_anaemia|Fanconi anaemia]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[CNS5:ELP1-medulloblastoma_syndrome|ELP1-medulloblastoma syndrome]]
 
|Disease
 
|Disease
 
|
 
|

Revision as of 12:28, 26 January 2024

WHO Classification of Tumours of the Central Nervous System (5th Edition) Content
Disease Page Type Author Date Assigned to Author Target Completion Date Author Content (Pending or Complete) Date Completed by Author Associate Editor Date of Last Editor Review Notes
Astrocytoma, IDH-mutant Disease
Oligodendroglioma, IDH-mutant and 1p/19q-codeleted Disease
Glioblastoma, IDH-wildtype Disease
Diffuse astrocytoma, MYB- or MYBL1-altered Disease
Angiocentric glioma Disease
Polymorphous low-grade neuroepithelial tumour of the young Disease
Diffuse low-grade glioma, MAPK pathway-altered Disease
Diffuse midline glioma, H3 K27-altered Disease
Diffuse hemispheric glioma, H3 G34-mutant Disease
Diffuse paediatric-type high-grade glioma, H3-wildtype and IDH-wildtype Disease
Infant-type hemispheric glioma Disease
Pilocytic astrocytoma Disease
High-grade astrocytoma with piloid features Disease
Pleomorphic xanthoastrocytoma Disease
Subependymal giant cell astrocytoma Disease
Chordoid glioma Disease
Astroblastoma, MN1-altered Disease
Ganglioglioma Disease
Gangliocytoma Disease
Desmoplastic infantile ganglioglioma / desmoplastic infantile astrocytoma Disease
Dysembryoplastic neuroepithelial tumour Disease
Diffuse glioneuronal tumour with oligodendroglioma-like features and nuclear clusters Disease
Papillary glioneuronal tumour Disease
Rosette-forming glioneuronal tumour Disease
Myxoid glioneuronal tumour Disease
Diffuse leptomeningeal glioneuronal tumour Disease
Multinodular and vacuolating neuronal tumour Disease
Dysplastic cerebellar gangliocytoma (Lhermitte-Duclos disease) Disease
Central neurocytoma Disease
Extraventricular neurocytoma Disease
Cerebellar liponeurocytoma Disease
Supratentorial ependymoma Disease
Supratentorial ependymoma, ZFTA fusion-positive Disease
Supratentorial ependymoma, YAP1 fusion-positive Disease
Posterior fossa ependymoma Disease
Posterior fossa group A (PFA) ependymoma Disease
Posterior fossa group B (PFB) ependymoma Disease
Spinal ependymoma Disease
Spinal ependymoma, MYCN-amplified Disease
Myxopapillary ependymoma Disease
Subependymoma Disease
Choroid plexus papilloma Disease
Atypical choroid plexus papilloma Disease
Choroid plexus carcinoma Disease
Medulloblastoma, WNT-activated Disease
Medulloblastoma, SHH-activated and TP53-wildtype Disease
Medulloblastoma, SHH-activated and TP53-mutant Disease
Medulloblastoma, non-WNT/non-SHH Disease
Medulloblastoma, histologically defined Disease
Atypical teratoid/rhabdoid tumour Disease
Cribriform neuroepithelial tumour Disease
Embryonal tumour with multilayered rosettes Disease
CNS neuroblastoma, FOXR2-activated Disease
CNS tumour with BCOR internal tandem duplication Disease
CNS embryonal tumour NEC/NOS Disease
Pineocytoma Disease
Pineal parenchymal tumour of intermediate differentiation Disease
Pineoblastoma Disease
Papillary tumour of the pineal region Disease
Desmoplastic myxoid tumour of the pineal region, SMARCB1-mutant Disease
Schwannoma Disease
Neurofibroma Disease
Perineurioma Disease
Hybrid nerve sheath tumours Disease
Malignant melanotic nerve sheath tumour Disease
Malignant peripheral nerve sheath tumour Disease
Cauda equina neuroendocrine tumour (previously paraganglioma) Disease
Meningioma Disease
Solitary fibrous tumour Disease
Haemangiomas and vascular malformations Disease
Haemangioblastoma Disease
Rhabdomyosarcoma Disease
Intracranial mesenchymal tumour, FET::CREB fusion-positive Disease
CIC-rearranged sarcoma Disease
Primary intracranial sarcoma, DICER1-mutant Disease
Ewing sarcoma Disease
Mesenchymal chondrosarcoma Disease
Chondrosarcoma Disease
Chordoma Disease
Diffuse meningeal melanocytic neoplasms: Melanocytosis and melanomatosis Disease
Circumscribed meningeal melanocytic neoplasms: Melanocytoma and melanoma Disease
Primary diffuse large B-cell lymphoma of the CNS Disease
Immunodeficiency-associated CNS lymphomas Disease
Lymphomatoid granulomatosis Disease
Intravascular large B-cell lymphoma Disease
MALT lymphoma of the dura Disease
Other low-grade B-cell lymphomas of the CNS Disease
Anaplastic large cell lymphoma (ALK+/ALK−) Disease
T-cell and NK/T-cell lymphomas Disease
Erdheim-Chester disease Disease
Rosai-Dorfman disease Disease
Juvenile xanthogranuloma Disease
Langerhans cell histiocytosis Disease
Histiocytic sarcoma Disease
Germ cell tumours of the CNS Disease
Adamantinomatous craniopharyngioma Disease
Papillary craniopharyngioma Disease
Pituicytoma, granular cell tumour of the sellar region, and spindle cell oncocytoma Disease
Pituitary adenoma / pituitary neuroendocrine tumour Disease
Pituitary blastoma Disease
Metastases to the brain and spinal cord parenchyma Disease
Metastases to the meninges Disease
Neurofibromatosis type 1 Disease
Neurofibromatosis type 2 Disease
Schwannomatosis Disease
Von Hippel-Lindau syndrome Disease
Tuberous sclerosis Disease
Li-Fraumeni syndrome Disease
Cowden syndrome Disease
Constitutional mismatch repair deficiency syndrome Disease
Familial adenomatous polyposis 1 Disease
Naevoid basal cell carcinoma syndrome Disease
Rhabdoid tumour predisposition syndrome Disease
Carney complex Disease
DICER1 syndrome Disease
Familial paraganglioma syndromes Disease
Melanoma-astrocytoma syndrome Disease
Familial retinoblastoma Disease
BAP1 tumour predisposition syndrome Disease
Fanconi anaemia Disease
ELP1-medulloblastoma syndrome Disease
Retrieved from "https://ccga.io/index.php?title=User:Bailey.Glen&oldid=14124"